Pharmacodynamic Models for Discrete Data View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2012-10-17

AUTHORS

Ines Paule, Pascal Girard, Gilles Freyer, Michel Tod

ABSTRACT

Clinical outcomes are often described as events: death, stroke, epileptic seizure, multiple sclerosis lesions, recurrence of cancer, disease progression, pain, infection and bacterial/viral eradication, severe toxic adverse effect, resistance to treatment, etc. They may be quantified as time-to-event, counts of events per time interval (rates), their severity grade, or a combination of these. Such data are discrete and require specific modelling structures and methods. This article references the most common modelling approaches for categorical, count and time-to-event data, and reviews examples of such models applied in the analysis of pharmacodynamic data. Modelling is useful for identification of influential factors related to the clinical outcome, characterization and quantification of their impact, for making better informed predictions and clinical decisions, assessments of efficacy of therapeutic interventions, optimizing the individual treatments and drug development studies. More... »

PAGES

767-786

References to SciGraph publications

  • 2004-08. Estimating Bias in Population Parameters for Some Models for Repeated Measures Ordinal Data Using NONMEM and NLMIXED in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 2000-08. A pharmacodynamic Markov mixed‐effect model for the effect of temazepam on sleep in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2009-03-10. Modeling Subpopulations with the $MIXTURE Subroutine in NONMEM: Finding the Individual Probability of Belonging to a Subpopulation for the Use in Model Analysis and Improved Decision Making in THE AAPS JOURNAL
  • 2007-09-19. Modeling and Simulation to Support Dose Selection and Clinical Development of SC‐75416, a Selective COX‐2 Inhibitor for the Treatment of Acute and Chronic Pain in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2011-08-02. Dose adaptation of capecitabine based on individual prediction of limiting toxicity grade: evaluation by clinical trial simulation in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1999-06. Quantitative characterization of therapeutic index: Application of mixed‐effects modeling to evaluate oxybutynin dose–efficacy and dose–side effect relationships in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2006-07-14. Modeling and Simulation of Sexual Activity Daily Diary Data of Patients with Female Sexual Arousal Disorder Treated with Sildenafil Citrate (Viagra®) in PHARMACEUTICAL RESEARCH
  • 2009-07-22. A Pharmacodynamic Markov Mixed‐Effects Model for Determining the Effect of Exposure to Certolizumab Pegol on the ACR20 Score in Patients With Rheumatoid Arthritis in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2008-02-06. Exposure‐response Analysis for Spontaneously Reported Dizziness in Pregabalin‐treated Patient With Generalized Anxiety Disorder in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2007-12-06. Exposure-response modeling using latent variables for the efficacy of a JAK3 inhibitor administered to rheumatoid arthritis patients in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 2011-06-17. Modeling Sleep Data for a New Drug in Development using Markov Mixed-Effects Models in PHARMACEUTICAL RESEARCH
  • 1999-12-01. A Population Pharmacokinetic–Pharmacodynamic Analysis of Repeated Measures Time-to-Event Pharmacodynamic Responses: The Antiemetic Effect of Ondansetron in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 2002-09. Clinical pharmacokinetics of irinotecan and its metabolites in relation with diarrhea in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2003-06. Exposure‐response analysis of pregabalin add‐on treatment of patients with refractory partial seizures in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2007-05. Exposure-Effect Population Model of Inolimomab, a Monoclonal Antibody Administered in First-Line Treatment for Acute Graft-Versus-Host Disease in CLINICAL PHARMACOKINETICS
  • 2006-08-09. Population Pharmacokinetic/Pharmacodynamic Modelling of the Analgesic Effects of Tramadol in Pediatrics in PHARMACEUTICAL RESEARCH
  • 1996-12. Population pharmacodynamic model for ketorolac analgesia in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2003-10. A Two-Part Mixture Model for Longitudinal Adverse Event Severity Data in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 2005-06. The analysis of ordered categorical data: An overview and a survey of recent developments in TEST
  • 2005-04. Modelling a Spontaneously Reported Side Effect by Use of a Markov Mixed-Effects Model in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 2009-10-02. Modelling overdispersion and Markovian features in count data in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 2002-05-06. Population pharmacokinetic and adverse event analysis of topotecan in patients with solid tumors in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2002-02. Determination of an Optimal Dosage Regimen Using a Bayesian Decision Analysis of Efficacy and Adverse Effect Data in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 2009-12-05. Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2005-04. Pharmacokinetic/Pharmacodynamic and Time-to-Event Models of Ribavirin-Induced Anaemia in Chronic Hepatitis C in CLINICAL PHARMACOKINETICS
  • 2003-02. A Joint Model for Nonlinear Longitudinal Data with Informative Dropout in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 2002-12-28. Population pharmacokinetic and pharmacodynamic modeling of propofol for long‐term sedation in critically ill patients: A comparison between propofol 6% and propofol 1% in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2011-02-13. Informative dropout modeling of longitudinal ordered categorical data and model validation: application to exposure–response modeling of physician’s global assessment score for ustekinumab in patients with psoriasis in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 2003-06. Evaluation of Mixture Modeling with Count Data Using NONMEM in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 2000-12. Clinical trial simulation of docetaxel in patients with cancer as a tool for dosage optimization in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2010-02-02. Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic–pharmacodynamic analysis from the IELSG no. 20 trial in BRITISH JOURNAL OF CANCER
  • 2010-07-23. A model of hypertension and proteinuria in cancer patients treated with the anti-angiogenic drug E7080 in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
  • 2002-06-17. Lessons learned from a phase III population pharmacokinetic study of cariporide in coronary artery bypass graft surgery in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 1994-09. A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s40262-012-0014-9

    DOI

    http://dx.doi.org/10.1007/s40262-012-0014-9

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1023935301

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/23179578


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Pharmacology and Pharmaceutical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug-Related Side Effects and Adverse Reactions", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Models, Biological", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Statistics as Topic", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "EMR3738, Facult\u00e9 de M\u00e9decine Lyon-sud, Universit\u00e9 Claude Bernard Lyon 1, Lyon, France", 
              "id": "http://www.grid.ac/institutes/grid.7849.2", 
              "name": [
                "EMR3738, Facult\u00e9 de M\u00e9decine Lyon-sud, Universit\u00e9 Claude Bernard Lyon 1, Lyon, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Paule", 
            "givenName": "Ines", 
            "id": "sg:person.0715576221.23", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0715576221.23"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Merck Serono S.A., Geneva, Switzerland", 
              "id": "http://www.grid.ac/institutes/grid.418389.f", 
              "name": [
                "EMR3738, Facult\u00e9 de M\u00e9decine Lyon-sud, Universit\u00e9 Claude Bernard Lyon 1, Lyon, France", 
                "Merck Serono S.A., Geneva, Switzerland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Girard", 
            "givenName": "Pascal", 
            "id": "sg:person.012661201622.56", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012661201622.56"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Service d\u2019Oncologie, Centre Hospitalier Lyon-sud, Hospices Civils de Lyon, Lyon, France", 
              "id": "http://www.grid.ac/institutes/grid.413852.9", 
              "name": [
                "EMR3738, Facult\u00e9 de M\u00e9decine Lyon-sud, Universit\u00e9 Claude Bernard Lyon 1, Lyon, France", 
                "Service d\u2019Oncologie, Centre Hospitalier Lyon-sud, Hospices Civils de Lyon, Lyon, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Freyer", 
            "givenName": "Gilles", 
            "id": "sg:person.0636233052.33", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636233052.33"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Pharmacie, H\u00f4pital de la Croix-Rousse, Hospices Civils de Lyon, 104 grande rue de la Croix-Rousse, 69004, Lyon, France", 
              "id": "http://www.grid.ac/institutes/grid.413306.3", 
              "name": [
                "EMR3738, Facult\u00e9 de M\u00e9decine Lyon-sud, Universit\u00e9 Claude Bernard Lyon 1, Lyon, France", 
                "Pharmacie, H\u00f4pital de la Croix-Rousse, Hospices Civils de Lyon, 104 grande rue de la Croix-Rousse, 69004, Lyon, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Tod", 
            "givenName": "Michel", 
            "id": "sg:person.0763711421.46", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0763711421.46"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.2165/00003088-200746050-00004", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016219511", 
              "https://doi.org/10.2165/00003088-200746050-00004"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/clpt.2009.136", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028183327", 
              "https://doi.org/10.1038/clpt.2009.136"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1023/a:1015720718875", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010964379", 
              "https://doi.org/10.1023/a:1015720718875"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1016/s0009-9236(96)90210-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1009934385", 
              "https://doi.org/10.1016/s0009-9236(96)90210-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1067/mcp.2002.129500", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001291627", 
              "https://doi.org/10.1067/mcp.2002.129500"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11095-011-0490-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037981801", 
              "https://doi.org/10.1007/s11095-011-0490-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11095-006-9049-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1040496982", 
              "https://doi.org/10.1007/s11095-006-9049-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1067/mcp.2002.126741", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049379553", 
              "https://doi.org/10.1067/mcp.2002.126741"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10928-011-9191-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025573704", 
              "https://doi.org/10.1007/s10928-011-9191-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10928-005-0021-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017453144", 
              "https://doi.org/10.1007/s10928-005-0021-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00280-011-1714-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1029124441", 
              "https://doi.org/10.1007/s00280-011-1714-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1023/b:jopa.0000042738.06821.61", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035346935", 
              "https://doi.org/10.1023/b:jopa.0000042738.06821.61"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00280-009-1170-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1042343030", 
              "https://doi.org/10.1007/s00280-009-1170-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.clpt.6100491", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035009189", 
              "https://doi.org/10.1038/sj.clpt.6100491"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1067/mcp.2000.111948", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036354098", 
              "https://doi.org/10.1067/mcp.2000.111948"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1023/a:1025564409649", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031535199", 
              "https://doi.org/10.1023/a:1025564409649"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1016/s0009-9236(03)00049-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002339391", 
              "https://doi.org/10.1016/s0009-9236(03)00049-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10928-010-9164-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041046109", 
              "https://doi.org/10.1007/s10928-010-9164-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/clpt.1994.142", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023675421", 
              "https://doi.org/10.1038/clpt.1994.142"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1067/mcp.2002.123553", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046370700", 
              "https://doi.org/10.1067/mcp.2002.123553"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10928-009-9131-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025574600", 
              "https://doi.org/10.1007/s10928-009-9131-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1067/mcp.2002.124078", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1053014513", 
              "https://doi.org/10.1067/mcp.2002.124078"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf02595397", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1044079960", 
              "https://doi.org/10.1007/bf02595397"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11095-006-9007-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1004542861", 
              "https://doi.org/10.1007/s11095-006-9007-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1208/s12248-009-9093-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017889519", 
              "https://doi.org/10.1208/s12248-009-9093-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00003088-200544040-00006", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1004107052", 
              "https://doi.org/10.2165/00003088-200544040-00006"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1016/s0009-9236(99)90089-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003156832", 
              "https://doi.org/10.1016/s0009-9236(99)90089-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1023/a:1023249510224", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019286936", 
              "https://doi.org/10.1023/a:1023249510224"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10928-007-9080-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014416534", 
              "https://doi.org/10.1007/s10928-007-9080-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.clpt.6100374", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1007304423", 
              "https://doi.org/10.1038/sj.clpt.6100374"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6605559", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051800259", 
              "https://doi.org/10.1038/sj.bjc.6605559"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1023/a:1020930626404", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018407227", 
              "https://doi.org/10.1023/a:1020930626404"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1067/mcp.2000.108669", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037395254", 
              "https://doi.org/10.1067/mcp.2000.108669"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1023/b:jopa.0000008157.26321.3c", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016583332", 
              "https://doi.org/10.1023/b:jopa.0000008157.26321.3c"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2012-10-17", 
        "datePublishedReg": "2012-10-17", 
        "description": "Clinical outcomes are often described as events: death, stroke, epileptic seizure, multiple sclerosis lesions, recurrence of cancer, disease progression, pain, infection and bacterial/viral eradication, severe toxic adverse effect, resistance to treatment, etc. They may be quantified as time-to-event, counts of events per time interval (rates), their severity grade, or a combination of these. Such data are discrete and require specific modelling structures and methods. This article references the most common modelling approaches for categorical, count and time-to-event data, and reviews examples of such models applied in the analysis of pharmacodynamic data. Modelling is useful for identification of influential factors related to the clinical outcome, characterization and quantification of their impact, for making better informed predictions and clinical decisions, assessments of efficacy of therapeutic interventions, optimizing the individual treatments and drug development studies.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s40262-012-0014-9", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1085321", 
            "issn": [
              "0312-5963", 
              "1179-1926"
            ], 
            "name": "Clinical Pharmacokinetics", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "12", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "51"
          }
        ], 
        "keywords": [
          "clinical outcomes", 
          "assessment of efficacy", 
          "recurrence of cancer", 
          "toxic adverse effects", 
          "multiple sclerosis lesions", 
          "viral eradication", 
          "drug development studies", 
          "disease progression", 
          "severity grade", 
          "pharmacodynamic data", 
          "pharmacodynamic model", 
          "epileptic seizures", 
          "therapeutic interventions", 
          "sclerosis lesions", 
          "clinical decision", 
          "adverse effects", 
          "individual treatment", 
          "outcomes", 
          "treatment", 
          "count", 
          "pain", 
          "recurrence", 
          "seizures", 
          "lesions", 
          "stroke", 
          "cancer", 
          "infection", 
          "progression", 
          "death", 
          "efficacy", 
          "eradication", 
          "development studies", 
          "time interval", 
          "intervention", 
          "events", 
          "grade", 
          "data", 
          "interval", 
          "assessment", 
          "counts of events", 
          "factors", 
          "event data", 
          "study", 
          "time", 
          "effect", 
          "resistance", 
          "influential factors", 
          "combination", 
          "identification", 
          "such data", 
          "quantification", 
          "impact", 
          "analysis", 
          "model", 
          "decisions", 
          "common modelling approaches", 
          "method", 
          "article", 
          "approach", 
          "characterization", 
          "prediction", 
          "such models", 
          "modelling approach", 
          "structure", 
          "modelling structure", 
          "example", 
          "modelling", 
          "discrete data"
        ], 
        "name": "Pharmacodynamic Models for Discrete Data", 
        "pagination": "767-786", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1023935301"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s40262-012-0014-9"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "23179578"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s40262-012-0014-9", 
          "https://app.dimensions.ai/details/publication/pub.1023935301"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-09-02T15:56", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_574.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s40262-012-0014-9"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s40262-012-0014-9'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s40262-012-0014-9'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s40262-012-0014-9'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s40262-012-0014-9'


     

    This table displays all metadata directly associated to this object as RDF triples.

    314 TRIPLES      21 PREDICATES      130 URIs      88 LITERALS      11 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s40262-012-0014-9 schema:about N751e5d0867374007bbb62d5b86c49481
    2 Nb1d5d2ba1f324e798a94df2133a87ba7
    3 Nde02e29df6d84837b991da1b18b56efc
    4 Nf13aec0ffa184988a82557f972b24c4d
    5 anzsrc-for:11
    6 anzsrc-for:1115
    7 schema:author Nd255d94ae84f4e048cf49ee1384c2c85
    8 schema:citation sg:pub.10.1007/bf02595397
    9 sg:pub.10.1007/s00280-009-1170-y
    10 sg:pub.10.1007/s00280-011-1714-9
    11 sg:pub.10.1007/s10928-005-0021-7
    12 sg:pub.10.1007/s10928-007-9080-2
    13 sg:pub.10.1007/s10928-009-9131-y
    14 sg:pub.10.1007/s10928-010-9164-2
    15 sg:pub.10.1007/s10928-011-9191-7
    16 sg:pub.10.1007/s11095-006-9007-4
    17 sg:pub.10.1007/s11095-006-9049-7
    18 sg:pub.10.1007/s11095-011-0490-x
    19 sg:pub.10.1016/s0009-9236(03)00049-3
    20 sg:pub.10.1016/s0009-9236(96)90210-6
    21 sg:pub.10.1016/s0009-9236(99)90089-9
    22 sg:pub.10.1023/a:1015720718875
    23 sg:pub.10.1023/a:1020930626404
    24 sg:pub.10.1023/a:1023249510224
    25 sg:pub.10.1023/a:1025564409649
    26 sg:pub.10.1023/b:jopa.0000008157.26321.3c
    27 sg:pub.10.1023/b:jopa.0000042738.06821.61
    28 sg:pub.10.1038/clpt.1994.142
    29 sg:pub.10.1038/clpt.2009.136
    30 sg:pub.10.1038/sj.bjc.6605559
    31 sg:pub.10.1038/sj.clpt.6100374
    32 sg:pub.10.1038/sj.clpt.6100491
    33 sg:pub.10.1067/mcp.2000.108669
    34 sg:pub.10.1067/mcp.2000.111948
    35 sg:pub.10.1067/mcp.2002.123553
    36 sg:pub.10.1067/mcp.2002.124078
    37 sg:pub.10.1067/mcp.2002.126741
    38 sg:pub.10.1067/mcp.2002.129500
    39 sg:pub.10.1208/s12248-009-9093-4
    40 sg:pub.10.2165/00003088-200544040-00006
    41 sg:pub.10.2165/00003088-200746050-00004
    42 schema:datePublished 2012-10-17
    43 schema:datePublishedReg 2012-10-17
    44 schema:description Clinical outcomes are often described as events: death, stroke, epileptic seizure, multiple sclerosis lesions, recurrence of cancer, disease progression, pain, infection and bacterial/viral eradication, severe toxic adverse effect, resistance to treatment, etc. They may be quantified as time-to-event, counts of events per time interval (rates), their severity grade, or a combination of these. Such data are discrete and require specific modelling structures and methods. This article references the most common modelling approaches for categorical, count and time-to-event data, and reviews examples of such models applied in the analysis of pharmacodynamic data. Modelling is useful for identification of influential factors related to the clinical outcome, characterization and quantification of their impact, for making better informed predictions and clinical decisions, assessments of efficacy of therapeutic interventions, optimizing the individual treatments and drug development studies.
    45 schema:genre article
    46 schema:isAccessibleForFree false
    47 schema:isPartOf N5ea25b8906774d03b8eaabd53322f6e1
    48 N92202151f2ab4e57a53a5da3262c8f3f
    49 sg:journal.1085321
    50 schema:keywords adverse effects
    51 analysis
    52 approach
    53 article
    54 assessment
    55 assessment of efficacy
    56 cancer
    57 characterization
    58 clinical decision
    59 clinical outcomes
    60 combination
    61 common modelling approaches
    62 count
    63 counts of events
    64 data
    65 death
    66 decisions
    67 development studies
    68 discrete data
    69 disease progression
    70 drug development studies
    71 effect
    72 efficacy
    73 epileptic seizures
    74 eradication
    75 event data
    76 events
    77 example
    78 factors
    79 grade
    80 identification
    81 impact
    82 individual treatment
    83 infection
    84 influential factors
    85 interval
    86 intervention
    87 lesions
    88 method
    89 model
    90 modelling
    91 modelling approach
    92 modelling structure
    93 multiple sclerosis lesions
    94 outcomes
    95 pain
    96 pharmacodynamic data
    97 pharmacodynamic model
    98 prediction
    99 progression
    100 quantification
    101 recurrence
    102 recurrence of cancer
    103 resistance
    104 sclerosis lesions
    105 seizures
    106 severity grade
    107 stroke
    108 structure
    109 study
    110 such data
    111 such models
    112 therapeutic interventions
    113 time
    114 time interval
    115 toxic adverse effects
    116 treatment
    117 viral eradication
    118 schema:name Pharmacodynamic Models for Discrete Data
    119 schema:pagination 767-786
    120 schema:productId N621c32a3c6424fc38594674263ab933e
    121 Ncc051f0614394806a959ddc4b5eeb698
    122 Nf3954c537491428faacea93552245abd
    123 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023935301
    124 https://doi.org/10.1007/s40262-012-0014-9
    125 schema:sdDatePublished 2022-09-02T15:56
    126 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    127 schema:sdPublisher N3647a82daa634163a1156ed9283ec810
    128 schema:url https://doi.org/10.1007/s40262-012-0014-9
    129 sgo:license sg:explorer/license/
    130 sgo:sdDataset articles
    131 rdf:type schema:ScholarlyArticle
    132 N174396f4c2a3454f8f8d430a1154966f rdf:first sg:person.012661201622.56
    133 rdf:rest N8bb25a3028214844b44bfaab3ec5d767
    134 N3647a82daa634163a1156ed9283ec810 schema:name Springer Nature - SN SciGraph project
    135 rdf:type schema:Organization
    136 N5ea25b8906774d03b8eaabd53322f6e1 schema:issueNumber 12
    137 rdf:type schema:PublicationIssue
    138 N621c32a3c6424fc38594674263ab933e schema:name pubmed_id
    139 schema:value 23179578
    140 rdf:type schema:PropertyValue
    141 N751e5d0867374007bbb62d5b86c49481 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    142 schema:name Models, Biological
    143 rdf:type schema:DefinedTerm
    144 N8209868ebe9c42c3b5f98df574450a7d rdf:first sg:person.0763711421.46
    145 rdf:rest rdf:nil
    146 N8bb25a3028214844b44bfaab3ec5d767 rdf:first sg:person.0636233052.33
    147 rdf:rest N8209868ebe9c42c3b5f98df574450a7d
    148 N92202151f2ab4e57a53a5da3262c8f3f schema:volumeNumber 51
    149 rdf:type schema:PublicationVolume
    150 Nb1d5d2ba1f324e798a94df2133a87ba7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    151 schema:name Drug-Related Side Effects and Adverse Reactions
    152 rdf:type schema:DefinedTerm
    153 Ncc051f0614394806a959ddc4b5eeb698 schema:name dimensions_id
    154 schema:value pub.1023935301
    155 rdf:type schema:PropertyValue
    156 Nd255d94ae84f4e048cf49ee1384c2c85 rdf:first sg:person.0715576221.23
    157 rdf:rest N174396f4c2a3454f8f8d430a1154966f
    158 Nde02e29df6d84837b991da1b18b56efc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    159 schema:name Statistics as Topic
    160 rdf:type schema:DefinedTerm
    161 Nf13aec0ffa184988a82557f972b24c4d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    162 schema:name Humans
    163 rdf:type schema:DefinedTerm
    164 Nf3954c537491428faacea93552245abd schema:name doi
    165 schema:value 10.1007/s40262-012-0014-9
    166 rdf:type schema:PropertyValue
    167 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    168 schema:name Medical and Health Sciences
    169 rdf:type schema:DefinedTerm
    170 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
    171 schema:name Pharmacology and Pharmaceutical Sciences
    172 rdf:type schema:DefinedTerm
    173 sg:journal.1085321 schema:issn 0312-5963
    174 1179-1926
    175 schema:name Clinical Pharmacokinetics
    176 schema:publisher Springer Nature
    177 rdf:type schema:Periodical
    178 sg:person.012661201622.56 schema:affiliation grid-institutes:grid.418389.f
    179 schema:familyName Girard
    180 schema:givenName Pascal
    181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012661201622.56
    182 rdf:type schema:Person
    183 sg:person.0636233052.33 schema:affiliation grid-institutes:grid.413852.9
    184 schema:familyName Freyer
    185 schema:givenName Gilles
    186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636233052.33
    187 rdf:type schema:Person
    188 sg:person.0715576221.23 schema:affiliation grid-institutes:grid.7849.2
    189 schema:familyName Paule
    190 schema:givenName Ines
    191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0715576221.23
    192 rdf:type schema:Person
    193 sg:person.0763711421.46 schema:affiliation grid-institutes:grid.413306.3
    194 schema:familyName Tod
    195 schema:givenName Michel
    196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0763711421.46
    197 rdf:type schema:Person
    198 sg:pub.10.1007/bf02595397 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044079960
    199 https://doi.org/10.1007/bf02595397
    200 rdf:type schema:CreativeWork
    201 sg:pub.10.1007/s00280-009-1170-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1042343030
    202 https://doi.org/10.1007/s00280-009-1170-y
    203 rdf:type schema:CreativeWork
    204 sg:pub.10.1007/s00280-011-1714-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029124441
    205 https://doi.org/10.1007/s00280-011-1714-9
    206 rdf:type schema:CreativeWork
    207 sg:pub.10.1007/s10928-005-0021-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017453144
    208 https://doi.org/10.1007/s10928-005-0021-7
    209 rdf:type schema:CreativeWork
    210 sg:pub.10.1007/s10928-007-9080-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014416534
    211 https://doi.org/10.1007/s10928-007-9080-2
    212 rdf:type schema:CreativeWork
    213 sg:pub.10.1007/s10928-009-9131-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1025574600
    214 https://doi.org/10.1007/s10928-009-9131-y
    215 rdf:type schema:CreativeWork
    216 sg:pub.10.1007/s10928-010-9164-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041046109
    217 https://doi.org/10.1007/s10928-010-9164-2
    218 rdf:type schema:CreativeWork
    219 sg:pub.10.1007/s10928-011-9191-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025573704
    220 https://doi.org/10.1007/s10928-011-9191-7
    221 rdf:type schema:CreativeWork
    222 sg:pub.10.1007/s11095-006-9007-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004542861
    223 https://doi.org/10.1007/s11095-006-9007-4
    224 rdf:type schema:CreativeWork
    225 sg:pub.10.1007/s11095-006-9049-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040496982
    226 https://doi.org/10.1007/s11095-006-9049-7
    227 rdf:type schema:CreativeWork
    228 sg:pub.10.1007/s11095-011-0490-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1037981801
    229 https://doi.org/10.1007/s11095-011-0490-x
    230 rdf:type schema:CreativeWork
    231 sg:pub.10.1016/s0009-9236(03)00049-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002339391
    232 https://doi.org/10.1016/s0009-9236(03)00049-3
    233 rdf:type schema:CreativeWork
    234 sg:pub.10.1016/s0009-9236(96)90210-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009934385
    235 https://doi.org/10.1016/s0009-9236(96)90210-6
    236 rdf:type schema:CreativeWork
    237 sg:pub.10.1016/s0009-9236(99)90089-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003156832
    238 https://doi.org/10.1016/s0009-9236(99)90089-9
    239 rdf:type schema:CreativeWork
    240 sg:pub.10.1023/a:1015720718875 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010964379
    241 https://doi.org/10.1023/a:1015720718875
    242 rdf:type schema:CreativeWork
    243 sg:pub.10.1023/a:1020930626404 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018407227
    244 https://doi.org/10.1023/a:1020930626404
    245 rdf:type schema:CreativeWork
    246 sg:pub.10.1023/a:1023249510224 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019286936
    247 https://doi.org/10.1023/a:1023249510224
    248 rdf:type schema:CreativeWork
    249 sg:pub.10.1023/a:1025564409649 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031535199
    250 https://doi.org/10.1023/a:1025564409649
    251 rdf:type schema:CreativeWork
    252 sg:pub.10.1023/b:jopa.0000008157.26321.3c schema:sameAs https://app.dimensions.ai/details/publication/pub.1016583332
    253 https://doi.org/10.1023/b:jopa.0000008157.26321.3c
    254 rdf:type schema:CreativeWork
    255 sg:pub.10.1023/b:jopa.0000042738.06821.61 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035346935
    256 https://doi.org/10.1023/b:jopa.0000042738.06821.61
    257 rdf:type schema:CreativeWork
    258 sg:pub.10.1038/clpt.1994.142 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023675421
    259 https://doi.org/10.1038/clpt.1994.142
    260 rdf:type schema:CreativeWork
    261 sg:pub.10.1038/clpt.2009.136 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028183327
    262 https://doi.org/10.1038/clpt.2009.136
    263 rdf:type schema:CreativeWork
    264 sg:pub.10.1038/sj.bjc.6605559 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051800259
    265 https://doi.org/10.1038/sj.bjc.6605559
    266 rdf:type schema:CreativeWork
    267 sg:pub.10.1038/sj.clpt.6100374 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007304423
    268 https://doi.org/10.1038/sj.clpt.6100374
    269 rdf:type schema:CreativeWork
    270 sg:pub.10.1038/sj.clpt.6100491 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035009189
    271 https://doi.org/10.1038/sj.clpt.6100491
    272 rdf:type schema:CreativeWork
    273 sg:pub.10.1067/mcp.2000.108669 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037395254
    274 https://doi.org/10.1067/mcp.2000.108669
    275 rdf:type schema:CreativeWork
    276 sg:pub.10.1067/mcp.2000.111948 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036354098
    277 https://doi.org/10.1067/mcp.2000.111948
    278 rdf:type schema:CreativeWork
    279 sg:pub.10.1067/mcp.2002.123553 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046370700
    280 https://doi.org/10.1067/mcp.2002.123553
    281 rdf:type schema:CreativeWork
    282 sg:pub.10.1067/mcp.2002.124078 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053014513
    283 https://doi.org/10.1067/mcp.2002.124078
    284 rdf:type schema:CreativeWork
    285 sg:pub.10.1067/mcp.2002.126741 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049379553
    286 https://doi.org/10.1067/mcp.2002.126741
    287 rdf:type schema:CreativeWork
    288 sg:pub.10.1067/mcp.2002.129500 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001291627
    289 https://doi.org/10.1067/mcp.2002.129500
    290 rdf:type schema:CreativeWork
    291 sg:pub.10.1208/s12248-009-9093-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017889519
    292 https://doi.org/10.1208/s12248-009-9093-4
    293 rdf:type schema:CreativeWork
    294 sg:pub.10.2165/00003088-200544040-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004107052
    295 https://doi.org/10.2165/00003088-200544040-00006
    296 rdf:type schema:CreativeWork
    297 sg:pub.10.2165/00003088-200746050-00004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016219511
    298 https://doi.org/10.2165/00003088-200746050-00004
    299 rdf:type schema:CreativeWork
    300 grid-institutes:grid.413306.3 schema:alternateName Pharmacie, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, 104 grande rue de la Croix-Rousse, 69004, Lyon, France
    301 schema:name EMR3738, Faculté de Médecine Lyon-sud, Université Claude Bernard Lyon 1, Lyon, France
    302 Pharmacie, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, 104 grande rue de la Croix-Rousse, 69004, Lyon, France
    303 rdf:type schema:Organization
    304 grid-institutes:grid.413852.9 schema:alternateName Service d’Oncologie, Centre Hospitalier Lyon-sud, Hospices Civils de Lyon, Lyon, France
    305 schema:name EMR3738, Faculté de Médecine Lyon-sud, Université Claude Bernard Lyon 1, Lyon, France
    306 Service d’Oncologie, Centre Hospitalier Lyon-sud, Hospices Civils de Lyon, Lyon, France
    307 rdf:type schema:Organization
    308 grid-institutes:grid.418389.f schema:alternateName Merck Serono S.A., Geneva, Switzerland
    309 schema:name EMR3738, Faculté de Médecine Lyon-sud, Université Claude Bernard Lyon 1, Lyon, France
    310 Merck Serono S.A., Geneva, Switzerland
    311 rdf:type schema:Organization
    312 grid-institutes:grid.7849.2 schema:alternateName EMR3738, Faculté de Médecine Lyon-sud, Université Claude Bernard Lyon 1, Lyon, France
    313 schema:name EMR3738, Faculté de Médecine Lyon-sud, Université Claude Bernard Lyon 1, Lyon, France
    314 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...